GLP-1 Receptor Agonist Clinical Evidence: Mental Health Links
Emerging research highlights GLP-1 receptor agonist mental health benefits beyond metabolic effects. Semaglutide shows promise in improving mood and psychiatric outcomes. Clinicians should consider these findings in patient care.
Correlates and Predictors of Criminal Legal Involvement in People With First-Episode Psychosis.
This study examines criminal legal involvement first-episode psychosis to identify key predictors influencing legal system contact. Understanding these factors aids clinicians in risk assessment and treatment planning. The findings highlight the…
Most European Countries Lack Evidence-Based Cannabis-Specific Treatment
Cannabis-specific treatment programs Europe remain limited and often lack evidence-based approaches. This 2025 overview reveals fragmented services with insufficient coverage. Structured psychosocial interventions are the most supported treatments for…
